From: Arterial health during early childhood following abnormal fetal growth
 | AGA (N = 48) | SGA (N = 23) | LGA (N = 19) | p-value | |||
---|---|---|---|---|---|---|---|
Gestation, birth and growth | Â | Â | Â | Â | Â | Â | |
Sex (male/female) | 27/21 | 56 %/44 % | 9/14 | 39 %/61 % | 9/10 | 47 %/53 % | 0.376 |
Age at follow-up (y) | 5.8 | 5.7;5.9 | 5.8 | 5.7;6.1 | 5.8 | 5.7;5.9 | 0.776 |
Maternal pre-pregnancy diabetes | 5 | 5 % | 0 | 0 % | 14*** | 74 % | < 0.001 |
Maternal pre-eclampsia | 3 | 6 % | 8** | 35 % | 1 | 5 % | 0.003 |
Mode of delivery (vaginal/caesarian)a | 31/16 | 65 %/33 % | 12/11 | 52 %/48 % | 7/12 | 37 %/63 % | 0.087 |
Gestational age at delivery (weeks) | 34.9 | 34.1;39.3 | 37.6 | 34.6;38.1 | 35.7 | 34.6;37.6 | 0.602 |
Birth height (cm) | 47 | 46; 51 | 43*** | 42; 46 | 51** | 49; 53 | < 0.001 |
Birth height Z-score (cm) | 0.43 | ±0.93 | -2.42*** | ±1.19 | 2.16*** | 0.98 | < 0.001 |
Birth weight (g) | 2550 | 2195;3474 | 2005*** | 1735:2390 | 4060*** | 3740;4480 | < 0.001 |
Birth weight (Z-score) | 0.06 | -0.69;0.85 | -2.67*** | -2.86;-1.97 | 3.87*** | 3.10;4.13 | < 0.001 |
Birth head circumference (cm) | 33.1 | ± 2.1 | 31.3*** | ±1.5 | 35.1*** | ±1.9 | < 0.001 |
Birth head circumference (Z-score) | 0.18 | 0.88 | -1.50*** | ±0.86 | 1.70*** | ±0.75 | < 0.001 |
Weight at 1 y (Z-score) | -0.03 | ±1.01 | -0.98** | ±1.30 | 0.39 | ±0.76 | < 0.001 |
Anthropometric data at 5y | Â | Â | Â | Â | Â | Â | Â |
Head circumference (cm) | 52.1 | ±1.4 | 51.1** | ±1.4 | 52.7 | ±1.3 | < 0.001 |
Head circumference (Z-score) | -0.25 | ±0.98 | -0.94* | ±1.24 | 0.29 | ±0.96 | 0.001 |
Height (cm) | 116.8 | ±4.5 | 111.8*** | ±4.5 | 117.5 | ±3.6 | < 0.001 |
Height (Z-score) | -0.03 | ±0.90 | -1.15*** | ±1.06 | 0.18 | ±0.65 | < 0.001 |
Weight (kg) | 20.1 | 18.0;22.3 | 17.9** | 15.2;20.7 | 22.6** | 21.2;23.9 | < 0.001 |
Weight (Z-score) | -0.83 | ±1.28 | -1.48 | ±2.02 | 0.38*** | ±1.03 | < 0.001 |
Body surface area (m2) | 0.81 | ±0.07 | 0.75** | ±0.08 | 0.86* | ±0.07 | < 0.001 |
Lean body mass (kg) | 17.7 | ±1.9 | 15.8*** | ±1.8 | 18.9* | ±1.6 | < 0.001 |
Arm length (cm) | 36.5 | ±2.0 | 35.3* | ±1.5 | 36.7 | ±2.1 | 0.036 |
Brachial circumference (cm) | 17.8 | ±1.5 | 16.9 | ±1.6 | 18.9* | ±1.6 | < 0.001 |
Antebrachial circumference (cm) | 17.0 | 16.4;17.7 | 16.5* | 15.1;17.0 | 17.5 | 16.8;18.8 | 0.002 |
Leg length (cm) | 58.9 | ±3.1 | 56.4** | ±3.6 | 60.1 | ±3.2 | 0.001 |
Thigh circumference (cm) | 32.7 | ±3.2 | 31.3 | ±3.0 | 35.0** | ±2.6 | < 0.001 |
Calf circumference (cm) | 23.0 | 21.9;24.8 | 22.0 | 20.9;23.5 | 24.8** | 24.3;25.5 | < 0.001 |
Adiposity data at 5y | Â | Â | Â | Â | Â | Â | Â |
Body mass index (kg/m2) | 14.9 | 14.0;15.7 | 13.9 | 13.1;15.9 | 16.1** | 15.3;16.9 | < 0.001 |
Body mass index (Z-score) | -0.80 | ±1.29 | -1.38 | ±1.92 | 0.38*** | ±1.04 | < 0.001 |
Body fat (%) | 13 | 9;16 | 8 | 4;15 | 15 | 12;18 | 0.046 |
Waist-hip ratio (no unit) | 0.92 | 0.89;0.95 | 0.90 | 0.87;0.94 | 0.89 | 0.88;0.93 | 0.330 |
Fasting state blood work at 5y | Â | Â | Â | Â | Â | Â | Â |
C-reactive protein (mg/l) | 0.35 | 0.23;0.94 | 0.41 | 0.19;0.90 | 0.31 | 0.21;0.68 | 0.865 |
Triglycerides (mmol/l) | 0.61 | 0.47;0.77 | 0.57 | 0.51;0.62 | 0.56 | 0.50;0.74 | 0.891 |
Low-density lipoprotein (mmol/l) | 2.48 | ±0.65 | 2.38 | ±0.56 | 2.69 | ±0.67 | 0.370 |
High-density lipoprotein (mmol/l) | 1.44 | ±0.34 | 1.50 | ±0.26 | 1.55 | ±0.27 | 0.501 |
Total cholesterol (mmol/l) | 4.14 | ±0.73 | 4.20 | ±0.60 | 4.41 | ±0.71 | 0.457 |
Glucose (mmol/l) | 5.1 | ±0.3 | 5.2 | ±0.4 | 4.9 | ±0.4 | 0.149 |
Insulin (mU/l) | 5.2 | 3.3;9.3 | 3.9 | 2.6;6.1 | 5.5 | 2.2;6.4 | 0.445 |
Glycated hemoglobin (mmol/mol) | 32 | ±2 | 31 | ±2 | 33 | ±2 | 0.220 |
Family smoking and SES at 5y | Â | Â | Â | Â | Â | Â | Â |
Smoking exposureb (yes/no) | 37/11 | 77 %/23 % | 16/5 | 70 %/22 % | 14/4 | 74 %/21 % | 1.000 |
Annual household incomec (≤30 000 €/ 30 001–70 000 €/ >70 000 €) | 9/16/23 | 19 %/33 %/48 % | 3/4/14 | 13 %/18 %/61 % | 3/5/9 | 16 %/26 %/47 % | 0.727 |
Upper secondary school completedb (neither parent/one parent/both parents) | 10/21/17 | 21 %/44 %/35 % | 2/8/11 | 9 %/35 %/48 % | 7/4/7 | 37 %/21 %/37 % | 0.179 |
AGA appropriate for gestational age, LGA large for gestational age, SES socioeconomic status, SGA small for gestational age. Data are given as mean ± SD, median Q1; Q3 or N and percentages, for normally, non-normally and nominal data, respectively. p-values correspond to ANOVA, Kruskal-Wallis or Fisher-Freeman-Halton exact test, as appropriate. Significant differences in post-hoc tests (Dunnet, Games-Howell. Mann-Whitney U or Z-test for proportions) between the SGA or LGA groups and the AGA group are indicated with *, **, ***, corresponding to significance levels of < 0.05, < 0.01 and < 0.001 respectively. aMode of delivery unknown for one AGA patient. bSmoking exposure and parental education status unknown for two SGA patients and one LGA patient. cAnnual household income unknown for two SGA and two LGA patients. |